Literature DB >> 16506855

Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.

Mira Rosenblat1, Nina Volkova, Raymond Coleman, Michael Aviram.   

Abstract

The effects of a pomegranate byproduct (PBP, which includes the whole pomegranate fruit left after juice preparation) on atherosclerosis development in apolipoprotein E-deficient (E degrees ) mice were studied. Consumption of PBP (17 or 51.5 microg of gallic acid equiv/kg/day) by the mice resulted in a significant reduction in atherosclerotic lesion size by up to 57%. PBP consumption significantly reduced oxidative stress in the mice peritoneal macrophages (MPM): Cellular lipid peroxide content decreased by up to 42%, the reduced glutathione levels increased by up to 53%, and paraoxonase 2 lactonase activity increased by up to 50%, as compared to MPM from E degrees mice that consumed only water. Furthermore, oxidized low-density lipoprotein (Ox-LDL) uptake by the MPM was reduced by up to 19%. Similar results were observed also in vitro. Treatment of J774A.1 macrophages with PBP (10 or 50 micromol/L of total polyphenols) significantly decreased both cellular total peroxide content and Ox-LDL uptake. It was thus concluded that PBP significantly attenuates atherosclerosis development by its antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506855     DOI: 10.1021/jf0528207

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  24 in total

1.  Evaluation of the effect of Punica granatum juice and punicalagin on NFκB modulation in inflammatory bowel disease.

Authors:  Tanmay A Shah; Mihir Parikh; Kirti V Patel; Kalpana G Patel; Chaitanya G Joshi; Tejal R Gandhi
Journal:  Mol Cell Biochem       Date:  2016-06-28       Impact factor: 3.396

2.  Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient mice.

Authors:  Aruna Poduri; Debra L Rateri; Shubin K Saha; Sibu Saha; Alan Daugherty
Journal:  J Nutr Biochem       Date:  2012-08-16       Impact factor: 6.048

3.  Pomegranate Intake Protects Against Genomic Instability Induced by Medical X-rays In Vivo in Mice.

Authors:  Sameera Nallanthighal; Amit B Shirode; Julius A Judd; Ramune Reliene
Journal:  Nutr Cancer       Date:  2016-09-27       Impact factor: 2.900

4.  Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment.

Authors:  Beste Ozben; Evrim Dursun; Emanuela Monari; Aurora Cuoghi; Stefania Bergamini; Aldo Tomasi; Tomris Ozben
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

5.  Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  Nutrition       Date:  2008-05-19       Impact factor: 4.008

Review 6.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

7.  Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5.

Authors:  Gulinigaer Anwaier; Guan Lian; Gui-Zhi Ma; Wan-Li Shen; Chih-I Lee; Pei-Ling Lee; Zhan-Ying Chang; Yun-Xia Wang; Xiao-Yu Tian; Xiao-Li Gao; Jeng-Jiann Chiu; Rong Qi
Journal:  Front Cell Dev Biol       Date:  2021-06-28

8.  Pomegranate supplementation improves affective and motor behavior in mice after radiation exposure.

Authors:  Melissa S Dulcich; Richard E Hartman
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

9.  Pomegranate Protection against Cardiovascular Diseases.

Authors:  Michael Aviram; Mira Rosenblat
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-18       Impact factor: 2.629

10.  Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2008-06-13       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.